Tag : completes

Latest News

Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia

Newsemia
BOSTON–(BUSINESS WIRE)–Vor Biopharma, an immuno-oncology company, today announced a $42 million Series A financing round led by 5AM Ventures and RA Capital Management. Source link...
Latest News

Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)

Newsemia
NEW YORK & LONDON–(BUSINESS WIRE)–Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics...
Latest News

Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept

Newsemia
DUBLIN & CAMBRIDGE, England–(BUSINESS WIRE)–Inflazome, a pioneering inflammasome company developing small molecule drugs that block harmful inflammation, today announces the successful completion of a Series...
Latest News

Arrowhead completes dosing of ARO-AAT Phase 1 study to treat rare genetic liver disease

Newsemia
Arrowhead Pharmaceuticals Inc. today announced that it has completed dosing of a Phase 1 clinical study of ARO-AAT, the company’s second generation subcutaneously administered RNA...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy